Yendou Revolutionizes Clinical Trials with $1.3M Pre-Seed Funding

Yendou, a Berlin-based startup, has secured $1.3 million in pre-seed funding to expand its clinical operations automation platform, likened to Salesforce for R&D teams in life sciences. Led by CEO Zina Sarif and co-founder Patrick Rogg, Yendou aims to streamline the cumbersome process of clinical trials, connecting clinicians and pharmaceutical companies seamlessly. Since its launch in March 2023, Yendou has gained traction from over 1,200 clinicians in 46 countries, showcasing its potential to transform the industry. With the support of investors like b2venture and angel investors from the pharmaceutical industry, Yendou is poised to revolutionize the way clinical trials are conducted, paving the way for faster and more efficient drug development processes.